At Topia Life Sciences, we are excited to introduce Alzevita, our latest breakthrough in Alzheimer’s Disease (AD) detection. Alzevita leverages state-of-the-art deep learning techniques to deliver precise segmentation and volumetric analysis of the hippocampus from brain MRI scans. This innovation is designed to significantly enhance early diagnosis and monitoring of Alzheimer’s disease, providing invaluable benefits for both research and clinical practice.

How It Works

Alzevita employs sophisticated techniques to achieve exceptional results in hippocampal segmentation:

• UNet++ Architecture: This advanced architecture features nested and dense skip connections, which enhance the accuracy of feature propagation and localization, crucial for detecting subtle changes in hippocampal structure.
• ResNet Backbone: Improves feature extraction, ensuring that even the most minute details of the hippocampus are captured accurately.
• Split Attention Mechanism: Focuses on relevant regions within the hippocampus, enhancing segmentation precision and reducing the likelihood of errors.

Users can upload their Brain T1 MRI scans in the DIACOM or NIfTI (.nii) format. Alzevita processes these scans to generate detailed segmentation masks of the hippocampus and calculates the volumes of the left and right hippocampi, providing essential quantitative data for assessing hippocampal atrophy.

Check Out Our Interactive Model Diagram:

Results That Matter

We have rigorously tested Alzevita on multiple datasets, demonstrating superior performance in hippocampal segmentation and analysis compared to traditional methods:

• HarP Dataset: Alzevita achieved an impressive Dice Coefficient of 0.9144 and an F1 Score of 0.9678.
• MICCAI Dataset: The model excelled with a Dice Coefficient of 0.9130 and an F1 Score of 0.9545.

Explore the Results:

Table 1: Contrastive experimental results on the HarP Datasets

Table 2: Contrastive experimental results on the MICCAI dataset

Why It Matters

Alzevita is a crucial tool for automating the analysis of hippocampal MRI scans. It provides researchers and clinicians with accurate measurements of hippocampal volume, supporting early diagnosis and effective monitoring of Alzheimer’s disease progression. This precision has the potential to transform both clinical practices and research methodologies.